TOKYO, June 30 (Reuters) - Takeda Pharmaceutical Co Ltd (4502.T: Quote, Profile, Research, Stock Buzz) said it had submitted to Japan’s health ministry a drug application for anti-cancer agent panitumumab for the treatment of colorectal cancer patients.
